 |
Video: What is a Stock Split?
|
 |
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Co.'s primary product candidate, pemvidutide (proposed INN), is a good laboratory practices-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and non-alcoholic steatohepatitis. In addition, Co. is developing HepTcell, an immunotherapeutic agent designed to achieve a functional cure for chronic hepatitis B. According to our ALT split history records, Altimmune has had 1 split. | |
 |

Altimmune (ALT) has 1 split in our ALT split history database. The split for ALT took place on September 14, 2018. This was a 1 for 30 reverse split, meaning for each 30 shares of ALT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as Altimmune conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ALT split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Altimmune shares, starting with a $10,000 purchase of ALT, presented on a split-history-adjusted basis factoring in the complete ALT split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/30/2017 |
|
End date: |
10/04/2023 |
|
Start price/share: |
$125.10 |
|
End price/share: |
$2.51 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.99% |
|
Average Annual Total Return: |
-45.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$200.71 |
|
Years: |
6.35 |
|
|
 |
Date |
Ratio |
09/14/2018 | 1 for 30 |
|
 |